Authors:
VANGRIENSVEN JMT
HUISMAN LGM
SCHOEMAKER HC
KLUFT C
COHEN AF
Citation: Jmt. Vangriensven et al., LOW-DOSE INFUSION OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR INHEALTHY-VOLUNTEERS TO INVESTIGATE THE BIODISTRIBUTION OF T-PA IN THE EARLY PHASE OF INFUSION, Fibrinolysis & proteolysis, 11(1), 1997, pp. 21-27
Citation: Lgm. Huisman et al., USEFULNESS AND LIMITATIONS OF ACTILYSE(R) FOR STANDARDIZATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) ASSAYS IN BLOOD, Fibrinolysis, 10, 1996, pp. 125-127
Authors:
ANDREOTTI F
PREVOST R
LUPI A
HAMILTON J
DEBART ACW
HUISMAN LGM
MASERI A
KLUFT C
Citation: F. Andreotti et al., CIRCADIAN PATTERNS OF PLASMA T-PA AND PAI-1 ANTIGEN LEVELS IN PATIENTS WITH SEVERE PERIPHERAL ATHEROSCLEROSIS, Fibrinolysis, 10, 1996, pp. 159-160
Authors:
VANGRIENSVEN JMT
HUISMAN LGM
STUURMAN T
DOOIJEWAARD G
KROON R
SCHOEMAKER RC
KLUFT K
COHEN AF
Citation: Jmt. Vangriensven et al., EFFECTS OF INCREASED LIVER BLOOD-FLOW ON THE KINETICS AND DYNAMICS OFRECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, Clinical pharmacology and therapeutics, 60(5), 1996, pp. 504-511
Citation: Lgm. Huisman et al., ON THE ROLE OF C1-INHIBITOR AS INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN PLASMA, Thrombosis and haemostasis, 73(3), 1995, pp. 466-471
Authors:
VANGRIENSVEN JMT
BURGGRAAF KJ
GERLOFF J
GUNZLER WA
BEIER H
KROON R
HUISMAN LGM
SCHOEMAKER RC
KLUFT K
COHEN AF
Citation: Jmt. Vangriensven et al., EFFECTS OF CHANGING LIVER BLOOD-FLOW BY EXERCISE AND FOOD ON KINETICSAND DYNAMICS OF SARUPLASE, Clinical pharmacology and therapeutics, 57(4), 1995, pp. 381-389
Citation: P. Meijer et al., AN IMPROVED METHOD FOR THE DETECTION OF ALPHA(2)-ANTIPLASMIN ACTIVITYON THE AUTOMATED COAGULATION ANALYZER MLA ELECTRA 1000C, Fibrinolysis, 8, 1994, pp. 160-162
Citation: Lgm. Huisman et al., ON THE ROLE OF C1-INHIBITOR AS INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1269-1269